ClinicalTrials.gg
Drug

Vonoprazan clinical trials

Also written TAK-438, Takecab and vocinti.

studies test it
100
open now
23
in phase 3
33
first study started
2007

How each study uses vonoprazan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the vonoprazan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 May 2022 · VOQUEZNA TRIPLE PAK · NDA 215152 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vonoprazan
45
Vonoprazan fumarate
4
Vonoprazan 20 mg
4
Vonoprazan (Reference)
2
Vonoprazan Tablets
2

Brand

Takecab
3
vocinti
2

Development codes

TAK-438
29

In one entry with another drug

Given together, or one or the other

Vonoprazan+Amoxicillin
2
Vonoprazan and Amoxicillin
2

Studies by the year they started

99 studies that test it; most in 2021 (14)

Studies that test vonoprazan, by start year
YearStudies
20072
20082
20101
20118
20125
20152
20163
20174
20195
20204
202114
202211
20237
202412
202512
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
23
Phase 2
7
Phase 3
33
Phase 4
26
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 48 · Other 52

Takeda (31) · Phathom Pharmaceuticals, Inc. (14) · Shandong University (5) · Nanjing First Hospital, Nanjing Medical University (4) · Asian Institute of Gastroenterology, India (4) · Alexandria University (3) · Fu Jen Catholic University Hospital (2) · Xijing Hospital of Digestive Diseases (2)

Often tested with

Tested in the same studies.

Amoxicillin (18) · Clarithromycin (6) · Esomeprazole (5) · Levofloxacin (4) · Tetracycline (4) · Metronidazole (3) · Bismuth (3) · Lansoprazole (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7, 2 in phase 3

Studies that test vonoprazan, phase 3 first.

Studies

Open first, then newest update. How each study uses vonoprazan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 100

See all 100 studies that test vonoprazan →

Given beside what is tested · 15 — vonoprazan is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with vonoprazan

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call vonoprazan · ClinicalTrials.gg INT005725

  • MeSH (NLM) C552956vonoprazanOne source NLM
  • UNII (FDA) 1R5L3J156GVONOPRAZANConfirmed FDA, NLM, Wikidata
  • RxNorm 2604577One source FDA
  • Wikidata Q27887191vonoprazanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152911VonoprazanOne source FDA
  • DrugBank DB11739One source Wikidata

Also registered as vonoprazan fumarate (UNII 4QW3X4AMLB · RxNorm 2604576).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.